1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cbl-b silenced human NK cells respond stronger to cytokine stimulation. (4th November 2015) Authors: Lametschwandtner, Guenther; Sachet, Monika; Haslinger, Isabella; Mühleisen, Hannes; Loibner, Hans Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cbl-b silenced human NK cells respond stronger to cytokine stimulation. Issue 2 (December 2015) Authors: Lametschwandtner, Guenther; Sachet, Monika; Haslinger, Isabella; Mühleisen, Hannes; Loibner, Hans Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors. Issue 8 (16th November 2016) Authors: Hintersteiner, Beate; Lingg, Nico; Zhang, Peiqing; Woen, Susanto; Hoi, Kong Meng; Stranner, Stefan; Wiederkum, Susanne; Mutschlechner, Oliver; Schuster, Manfred; Loibner, Hans; Jungbauer, Alois Journal: MAbs Issue: Volume 8:Issue 8(2016) Page Start: 1548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development of a personalized cellular ex-vivo cbl-b silencing cancer immunotherapy. (6th November 2014) Authors: Lametschwandtner, Guenther; Loibner, Hans; Sachet, Monika; Hayden, Hubert; Hassler, Michaela; Schuster, Manfred; Salzberg, Marc; Triozzi, Pierre; Friedl, Josef Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. Issue 12 (December 2018) Authors: Ladenstein, Ruth; Pötschger, Ulrike; Valteau-Couanet, Dominique; Luksch, Roberto; Castel, Victoria; Yaniv, Isaac; Laureys, Genevieve; Brock, Penelope; Michon, Jean Marie; Owens, Cormac; Trahair, Toby; Chan, Godfrey Chi Fung; Ruud, Ellen; Schroeder, Henrik; Beck Popovic, Maja; Schreier, Guenter; L... Journal: Lancet oncology Issue: Volume 19:Issue 12(2018) Page Start: 1617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients. (7th November 2013) Authors: Lode, Holger; Siebert, Nikolai; Kietz, Silke; Müller, Ina; Schuster, Manfred; Janzek, Evelyne; Wiederkum, Susanne; Mutschlechner, Oliver; Loibner, Hans Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2. (2nd December 2019) Authors: Troschke-Meurer, Sascha; Siebert, Nikolai; Marx, Madlen; Zumpe, Maxi; Ehlert, Karoline; Mutschlechner, Oliver; Loibner, Hans; Ladenstein, Ruth; Lode, Holger N. Journal: Oncoimmunology Issue: Volume 8:Number 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗